PICO Portalanswers from OpenAlex
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
PaperCitations, authors & open-access status
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer have?
PICO Portalcitation count
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer has 733 citations in the OpenAlex counts PICO Portal stores.
When was Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer published?
PICO Portalyear
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer has 2023 year in the PICO Portal index.
What is the open-access status of Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
PICO Portaloa status
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer has green oa status in the PICO Portal index.
What is the DOI of Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
PICO Portaldoi
The DOI for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is on the source record.
What is the PMID of Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
PICO Portalpmid
The PMID for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is on the source record.
What is the OpenAlex record for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
PICO Portalopenalex
The OpenAlex for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is on the source record.